Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV004020440 | SCV000252589 | benign | Familial adenomatous polyposis 1 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000309947 | SCV000451983 | likely benign | APC-Associated Polyposis Disorders | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Gene |
RCV001701788 | SCV000516690 | likely benign | not provided | 2019-12-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26447891, 27028212, 26900293) |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000426052 | SCV000600118 | likely benign | not specified | 2017-02-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000573062 | SCV000667229 | likely benign | Hereditary cancer-predisposing syndrome | 2015-01-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000573062 | SCV000681759 | benign | Hereditary cancer-predisposing syndrome | 2016-03-26 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000573062 | SCV002535774 | likely benign | Hereditary cancer-predisposing syndrome | 2021-07-16 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV002478697 | SCV002797292 | likely benign | Desmoid disease, hereditary; Familial adenomatous polyposis 1; Hepatocellular carcinoma; Gastric cancer; Colorectal cancer; Gastric adenocarcinoma and proximal polyposis of the stomach | 2022-05-17 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001701788 | SCV003916965 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | APC: BP4, BS1 |
Myriad Genetics, |
RCV004020440 | SCV004931783 | benign | Familial adenomatous polyposis 1 | 2024-02-23 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Institute for Biomarker Research, |
RCV000573062 | SCV005045449 | benign | Hereditary cancer-predisposing syndrome | 2024-03-12 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001701788 | SCV001930653 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000426052 | SCV001970867 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003947643 | SCV004761898 | benign | APC-related disorder | 2019-10-16 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |